Christopher Lee is currently a PhD Candidate in the joint Harvard-MIT Division of Health Sciences and Technology working in the Koch Institute for Integrative Cancer Research developing new drug delivery techniques and therapeutics for urological diseases. Additionally, Chris is also a co-founder of Recon Therapeutics, a medical device start-up focused on providing an improved platform to help patients mix, dose, and inject therapeutics that are delivered in a powered form. Among his various awards, Chris is a 2015 Forbes 30 Under 30 Honoree, a World Economic Forum Global Shaper, and an Inc.com top 50 young entrepreneur under 25.

His presence at SXSW 2016 is associated with his work as the Co-Director of MIT Hacking Medicine, an organization that is focused on energizing and connecting the best minds across the health ecosystem to solve meaningful healthcare challenges. To date, MIT Hacking Medicine has helped inspire the inception of nearly 20 companies that have subsequently raised over $90M in financing.